Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Suzuken Co ( (JP:9987) ) just unveiled an update.
Suzuken Co., Ltd. has announced an extraordinary gain from the sale of investment securities, amounting to ¥15,567 million, as part of a strategic review and reduction of its cross-shareholdings. This gain will be recorded in the financial results for the fiscal year ending March 31, 2026, but it will not affect the company’s earnings forecast as the impact has already been accounted for.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen6387.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. is a company that operates in the pharmaceutical distribution industry. It is traded on the Prime Markets of the Tokyo and Nagoya Stock Exchanges, and the Sapporo Securities Exchange.
Average Trading Volume: 178,621
Technical Sentiment Signal: Buy
Current Market Cap: Yen330.5B
For a thorough assessment of 9987 stock, go to TipRanks’ Stock Analysis page.